This inventor holds 5 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Huya Bioscience International, LLC, Huyabio International, LLC. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Reid P Bissonnette: Innovator in Cancer Treatment
Introduction
Reid P Bissonnette is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of cancer treatment through his innovative approaches and patented therapies. With a total of 5 patents, Bissonnette has focused on developing combination therapies that enhance the effectiveness of existing cancer treatments.
Latest Patents
Bissonnette's latest patents include groundbreaking work on combination therapies of HDAC inhibitors and PD-1 inhibitors. These combinations are designed to treat cancer by reducing and preventing metastasis. Additionally, he has developed therapies that combine HDAC inhibitors with PD-L1 inhibitors, which are particularly useful for treating cancers that have shown resistance to PD-1 inhibitors.
Career Highlights
Throughout his career, Reid P Bissonnette has worked with notable companies such as Huya Bioscience International and Huyabio International. His work in these organizations has allowed him to advance his research and contribute to the development of innovative cancer therapies.
Collaborations
Bissonnette has collaborated with esteemed colleagues, including Alain Rolland and Mireille Gillings. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.
Conclusion
Reid P Bissonnette's contributions to cancer treatment through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the field of oncology.